Green Dye 3 vs Advantame: which is worse?

What is Green Dye 3?

Green Dye 3 (Fast Green FCF) is a synthetic blue-green triarylmethane dye similar to Blue Dye 1. It produces a sea-green color and is among the least used certified US food dyes. Its chemical formula is C37H34N2Na2O10S3.

What is Advantame?

Advantame is the newest FDA-approved synthetic sweetener, approved in 2014. Like neotame, it is a structural derivative of aspartame but with a vanillin-derived substituent. It is approximately 20,000 times sweeter than sucrose — the most potent sweetener currently approved for food use in the US.

Documented risks

Green Dye 3: Green Dye 3 has a limited safety database compared to other certified food dyes, partly due to its infrequent use. A 1981 NTP bioassay (Technical Report 27) found statistically significant increases in urinary bladder tumors in male mice at high doses. The FDA reviewed these findings and, as with Blue 2, concluded the doses far exceeded typical human dietary exposure. Green 3 is not approved in the EU — under the EU's positive list system, only specifically approved additives may be used. Since Green 3 is not on the positive list, it is effectively banned. EFSA has not conducted a formal re-evaluation because it is not authorized for EU use. Hypersensitivity reactions have been reported. Like other synthetic triarylmethane dyes, Green 3 may cause contact dermatitis. The FDA's April 2025 phase-out announcement includes Green 3 among the eight petroleum-based synthetic dyes to be removed from the US food supply. Its already limited use means this phase-out has minimal market impact compared to Red 40 or Yellow 5.

Advantame: Advantame is the newest approved high-intensity sweetener with the least post-approval safety data. The FDA approval was based on extensive pre-market animal studies showing no significant toxicity, carcinogenicity, reproductive toxicity, or neurotoxicity at relevant doses. EFSA approved it for EU use in 2014, finding no safety concerns based on the submitted data. Like other synthetic sweeteners, advantame has not been studied for long-term effects in large human populations post-approval. The same gut microbiome and glucose tolerance concerns raised for other sweeteners (aspartame, sucralose, acesulfame K) have not been specifically studied for advantame, though the class-wide concerns are relevant. Given its 2014 approval date, independent long-term safety studies are still limited.